Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according ...

A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...

Now, as a scientist at the University of Pennsylvania, Charly is working to rewrite the future of cancer treatment.

In HER2-positive early breast cancer, Kadcyla shows sustained improvement in both invasive disease-free survival and overall survival versus Herceptin.

Toon Van Gorp, MD, PhD, a MIRASOL trial investigator, emphasizes that the final analysis reinforces the efficacy of mirvetuximab soravtansine-gynx (Elahere; AbbVie) in patients with folate receptor ...

Accelerated aging in breast cancer survivors is linked to treatments and tumor characteristics, with implications for ...

Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen ...

The thyroid, a small but powerful butterfly-shaped gland at the front of the neck, plays a crucial role in regulating key ...

Bachelorette' star Katie Thurston, who was diagnosed with stage 3 invasive ductal carcinoma last month, opened up about how ...

After seeking medical care, Thurston said she was diagnosed with Stage 3 triple positive ductal carcinoma, a type of cancer where tumor cells have estrogen receptors, progesterone receptors, and HER2 ...

Puxitatug samrotecan (P-Sam), an investigational antibody-drug conjugate (ADC) targeting B7-H4-expressing tumors, showed ...

Hope for aggressive breast cancer. Survivors and doctors discuss breakthroughs, fears, and the need for inclusive research.